GGrantIndex
Sort

25,944 grants matching neurodegeneration

Core B: Clinical Core

$473,583
Benjamin Michael Hampstead · University Of Michigan At Ann Arbor · P30 · FY2018 · AG

Soluble guanylate cyclase in diabetic retinopathy

$473,552
Elia J Duh · Johns Hopkins University · R01 · FY2024 · EY

Soluble guanylate cyclase in diabetic retinopathy

$473,552
Elia J Duh · Johns Hopkins University · R01 · FY2025 · EY

Omega-3 and Blueberry Supplmentation in Age-Related Cognitive Decline

$473,528
Robert Krikorian · University Of Cincinnati · R01 · FY2011 · AG

Molecular Mechanism of LRRK2 Biology and Pathology in Parkinson's Disease

$473,440
Zhenyu Yue · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · NS

Spinocerebellar Ataxia Type 2 Gene and Gene Product

$473,383
Stefan M. Pulst · University Of Utah · R56 · FY2013 · NS

Assembly Mechanisms of RNA-Protein Complexes for Genetic Control

$473,342
Sarah A Woodson · Johns Hopkins University · R35 · FY2020 · GM

CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome

$473,186
Peter K Todd · University Of Michigan At Ann Arbor · R01 · FY2021 · NS

CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome

$473,186
Peter K Todd · University Of Michigan At Ann Arbor · R01 · FY2022 · NS

CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome

$473,186
Peter K Todd · University Of Michigan At Ann Arbor · R01 · FY2020 · NS

CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome

$473,186
Peter K Todd · University Of Michigan At Ann Arbor · R01 · FY2023 · NS

RNA Granules in Cerebellar Neurodegeneration

$473,112
Daniel R Scoles · University Of Utah · R01 · FY2017 · NS

A Comprehensive Proteomic Map of Mammalian Mitochondria

$473,089
Vamsi Krishna Mootha · Broad Institute, Inc. · R01 · FY2010 · GM

Altered Hippocampal Neurogenesis and Cognition via Maneb-mediated Changes in the Thiol Redox Proteome.

$473,078
James R Roede · University Of Colorado Denver · R01 · FY2018 · ES

Protein Arginine Deiminase 2 (PAD2) and Protein Citrullination in ALS

$473,033
Zuoshang Xu · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · NS

HIV Tat and Opiate-mediated aberrations in glial-neuronal crosstalk: Implications for the role of extracellular RNA in HAND

$472,930
Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2025 · DA

E3 ubiquitin ligase RNF145 in airway smooth muscle functions and in asthma

$472,898
Pawan Sharma · Thomas Jefferson University · R01 · FY2023 · HL

E3 ubiquitin ligase RNF145 in airway smooth muscle functions and in asthma

$472,898
Pawan Sharma · Thomas Jefferson University · R01 · FY2022 · HL

A TFEB and V-ATPase-mediated lysosomal stress sensing pathway in tauopathy

$472,810
Hui Zheng · Baylor College Of Medicine · P01 · FY2025 · AG

Biochemical and in vivo determinants of tau neurotoxicity

$472,747
Mel B Feany · Brigham And Women'S Hospital · R01 · FY2013 · NS

Yeast-based HTS Assay Technologies for Proteases

$472,725
John C Reed · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · AI

Homeostatic Role and Therapeutic Potential of the Neuroprotective Retinal Lipoxin Circuit

$472,715
Karsten Gronert · University Of California Berkeley · R01 · FY2022 · EY

Development of a blood-based test for neurodegenerative diseases

$472,695
Sandra Pankow · 3d Bioanalytix, Inc. · R41 · FY2024 · AG

Vesicular modulation of dopamine neuron toxicity

$472,657
Gary W Miller · Columbia University Health Sciences · R01 · FY2021 · ES

Role of R-loops in transcriptional stress, genome instability, and chronic immune response in Alzheimer's disease

$472,642
Hana Hall · Purdue University · R01 · FY2024 · NS